CBS PREMIUM ACCESS

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

Congress Presentation

About the speaker

Doctor Kateryna Sopova

University Medical Centre of Mannheim, Mannheim (Germany)
0 follower

1 more presentation in this session

Identifying potential drug targets for non-alcoholic fatty liver disease: a drug target Mendelian randomization study

Speaker: Miss N. Hukerikar (London, GB)

Thumbnail

Access the full session

Targets and markers of cardiometabolic disease

Speakers: Doctor K. Sopova, Miss N. Hukerikar
Thumbnail

About the event

Image

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations